vs
Freedom Holding Corp.（FRHC）与Surgery Partners, Inc.（SGRY）财务数据对比。点击上方公司名可切换其他公司
Surgery Partners, Inc.的季度营收约是Freedom Holding Corp.的1.4倍（$885.0M vs $628.6M），Freedom Holding Corp.净利率更高（12.1% vs -1.7%，领先13.8%），Surgery Partners, Inc.同比增速更快（2.4% vs -4.1%），Freedom Holding Corp.自由现金流更多（$651.7M vs $90.6M），过去两年Freedom Holding Corp.的营收复合增速更高（16.3% vs 11.1%）
Freedom Holding Corp.是在美国内华达州注册的投资集团，业务覆盖零售证券经纪交易、资产管理、资本市场服务、投研咨询、投行承销、抵押贷款、保险、银行及其他消费金融服务，核心布局美股、欧洲及以哈萨克斯坦为核心的中亚市场。
Surgery Partners, Inc.（NASDAQ代码：SGRY）旗下的United Surgical Partners International（USPI）是美国领先的日间手术护理服务商，总部位于得克萨斯州达拉斯，由唐·斯廷于1998年创立，专注于为患者提供便捷、高效的门诊外科医疗服务，运营多家合规手术中心，覆盖美国多地医疗需求场景。
FRHC vs SGRY — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $628.6M | $885.0M |
| 净利润 | $76.2M | $-15.0M |
| 毛利率 | 96.0% | — |
| 营业利润率 | 14.9% | 12.5% |
| 净利率 | 12.1% | -1.7% |
| 营收同比 | -4.1% | 2.4% |
| 净利润同比 | -2.6% | 86.2% |
| 每股收益（稀释后） | $1.25 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $628.6M | $885.0M | ||
| Q3 25 | $526.1M | $821.5M | ||
| Q2 25 | $533.4M | $826.2M | ||
| Q1 25 | $363.7M | $776.0M | ||
| Q4 24 | $655.2M | $864.4M | ||
| Q3 24 | $580.9M | $770.4M | ||
| Q2 24 | $450.7M | $762.1M | ||
| Q1 24 | $464.7M | $717.4M |
| Q4 25 | $76.2M | $-15.0M | ||
| Q3 25 | $38.7M | $-22.7M | ||
| Q2 25 | $30.4M | $-2.5M | ||
| Q1 25 | $-142.7M | $-37.7M | ||
| Q4 24 | $78.3M | $-108.5M | ||
| Q3 24 | $114.7M | $-31.7M | ||
| Q2 24 | $34.4M | $-15.5M | ||
| Q1 24 | $95.2M | $-12.4M |
| Q4 25 | 96.0% | — | ||
| Q3 25 | 97.1% | — | ||
| Q2 25 | 97.4% | — | ||
| Q1 25 | 96.6% | — | ||
| Q4 24 | 98.6% | — | ||
| Q3 24 | 99.1% | — | ||
| Q2 24 | 99.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | 14.9% | 12.5% | ||
| Q3 25 | 11.5% | 12.9% | ||
| Q2 25 | 7.6% | 13.5% | ||
| Q1 25 | -42.7% | 8.0% | ||
| Q4 24 | 15.0% | 14.7% | ||
| Q3 24 | 22.1% | 7.9% | ||
| Q2 24 | 9.2% | 11.1% | ||
| Q1 24 | 22.5% | 10.6% |
| Q4 25 | 12.1% | -1.7% | ||
| Q3 25 | 7.4% | -2.8% | ||
| Q2 25 | 5.7% | -0.3% | ||
| Q1 25 | -39.2% | -4.9% | ||
| Q4 24 | 11.9% | -12.6% | ||
| Q3 24 | 19.7% | -4.1% | ||
| Q2 24 | 7.6% | -2.0% | ||
| Q1 24 | 20.5% | -1.7% |
| Q4 25 | $1.25 | $-0.11 | ||
| Q3 25 | $0.63 | $-0.18 | ||
| Q2 25 | $0.50 | $-0.02 | ||
| Q1 25 | $-2.35 | $-0.30 | ||
| Q4 24 | $1.29 | $-0.86 | ||
| Q3 24 | $1.89 | $-0.25 | ||
| Q2 24 | $0.57 | $-0.12 | ||
| Q1 24 | $1.60 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $869.2M | $239.9M |
| 总债务越低越好 | — | $3.6B |
| 股东权益账面价值 | $1.4B | $1.7B |
| 总资产 | $12.4B | $8.1B |
| 负债/权益比越低杠杆越低 | — | 2.10× |
8季度趋势，按日历期对齐
| Q4 25 | $869.2M | $239.9M | ||
| Q3 25 | $636.0M | $203.4M | ||
| Q2 25 | $567.9M | $250.1M | ||
| Q1 25 | $837.3M | $229.3M | ||
| Q4 24 | $577.9M | $269.5M | ||
| Q3 24 | $569.2M | $221.8M | ||
| Q2 24 | $718.7M | $213.5M | ||
| Q1 24 | $545.1M | $185.2M |
| Q4 25 | — | $3.6B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $3.5B | ||
| Q1 25 | — | $3.4B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.0B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | $1.4B | $1.7B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.2B | $1.7B | ||
| Q4 24 | $1.3B | $1.8B | ||
| Q3 24 | $1.3B | $1.9B | ||
| Q2 24 | $1.1B | $2.0B | ||
| Q1 24 | $1.2B | $2.0B |
| Q4 25 | $12.4B | $8.1B | ||
| Q3 25 | $10.3B | $7.9B | ||
| Q2 25 | $9.7B | $8.0B | ||
| Q1 25 | $9.9B | $7.9B | ||
| Q4 24 | $9.1B | $7.9B | ||
| Q3 24 | $8.8B | $7.5B | ||
| Q2 24 | $8.5B | $7.5B | ||
| Q1 24 | $8.3B | $7.0B |
| Q4 25 | — | 2.10× | ||
| Q3 25 | — | 2.00× | ||
| Q2 25 | — | 1.98× | ||
| Q1 25 | — | 1.98× | ||
| Q4 24 | — | 1.83× | ||
| Q3 24 | — | 1.63× | ||
| Q2 24 | — | 1.56× | ||
| Q1 24 | — | 1.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $717.8M | $103.4M |
| 自由现金流经营现金流 - 资本支出 | $651.7M | $90.6M |
| 自由现金流率自由现金流/营收 | 103.7% | 10.2% |
| 资本支出强度资本支出/营收 | 10.5% | 1.4% |
| 现金转化率经营现金流/净利润 | 9.42× | — |
| 过去12个月自由现金流最近4个季度 | — | $195.6M |
8季度趋势，按日历期对齐
| Q4 25 | $717.8M | $103.4M | ||
| Q3 25 | $535.3M | $83.6M | ||
| Q2 25 | $480.8M | $81.3M | ||
| Q1 25 | $1.3B | $6.0M | ||
| Q4 24 | $-72.8M | $111.4M | ||
| Q3 24 | $-438.0M | $65.2M | ||
| Q2 24 | $854.1M | $82.8M | ||
| Q1 24 | $309.0M | $40.7M |
| Q4 25 | $651.7M | $90.6M | ||
| Q3 25 | $456.4M | $63.8M | ||
| Q2 25 | $450.0M | $57.9M | ||
| Q1 25 | — | $-16.7M | ||
| Q4 24 | $-92.7M | $89.1M | ||
| Q3 24 | $-447.5M | $45.0M | ||
| Q2 24 | $829.9M | $55.9M | ||
| Q1 24 | — | $19.7M |
| Q4 25 | 103.7% | 10.2% | ||
| Q3 25 | 86.7% | 7.8% | ||
| Q2 25 | 84.4% | 7.0% | ||
| Q1 25 | — | -2.2% | ||
| Q4 24 | -14.1% | 10.3% | ||
| Q3 24 | -77.0% | 5.8% | ||
| Q2 24 | 184.1% | 7.3% | ||
| Q1 24 | — | 2.7% |
| Q4 25 | 10.5% | 1.4% | ||
| Q3 25 | 15.0% | 2.4% | ||
| Q2 25 | 5.8% | 2.8% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | 3.0% | 2.6% | ||
| Q3 24 | 1.6% | 2.6% | ||
| Q2 24 | 5.4% | 3.5% | ||
| Q1 24 | — | 2.9% |
| Q4 25 | 9.42× | — | ||
| Q3 25 | 13.82× | — | ||
| Q2 25 | 15.82× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.93× | — | ||
| Q3 24 | -3.82× | — | ||
| Q2 24 | 24.83× | — | ||
| Q1 24 | 3.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRHC
暂无分部数据
SGRY
| Private Insurance | $460.5M | 52% |
| Government Revenue | $368.6M | 42% |
| Other | $19.8M | 2% |
| Self Pay Revenue | $19.6M | 2% |
| Other Patient Service Revenue Sources | $16.5M | 2% |
